University of Lille-Nord de France, F-59000 Lille, France.
Curr Top Med Chem. 2012;12(6):486-504. doi: 10.2174/156802612799436641.
Nuclear receptors (NRs) regulate and coordinate multiple processes by integrating internal and external signals, thereby maintaining homeostasis in front of nutritional, behavioral and environmental challenges. NRs exhibit strong similarities in their structure and mode of action: by selective transcriptional activation or repression of cognate target genes, which can either be controlled through a direct, DNA binding-dependent mechanism or through crosstalk with other transcriptional regulators, NRs modulate the expression of gene clusters thus achieving coordinated tissue responses. Additionally, non genomic effects of NR ligands appear mediated by ill-defined mechanisms at the plasma membrane. These effects mediate potential therapeutic effects as small lipophilic molecule targets, and many efforts have been put in elucidating their precise mechanism of action and pathophysiological roles. Currently, numerous nuclear receptor ligand analogs are used in therapy or are tested in clinical trials against various diseases such as hypertriglyceridemia, atherosclerosis, diabetes, allergies and cancer and others.
核受体(NRs)通过整合内外信号来调节和协调多种过程,从而在营养、行为和环境挑战面前维持体内平衡。NRs 在结构和作用方式上具有很强的相似性:通过对同源靶基因的选择性转录激活或抑制,这些基因可以通过直接的、依赖 DNA 结合的机制或通过与其他转录调节剂的串扰来控制,NRs 调节基因簇的表达,从而实现协调的组织反应。此外,NR 配体的非基因组效应似乎通过质膜上定义不明确的机制来介导。这些效应通过作为小分子亲脂性靶标的潜在治疗效果来介导,并且已经做出了许多努力来阐明其确切的作用机制和病理生理作用。目前,许多核受体配体类似物被用于治疗或正在临床试验中针对各种疾病进行测试,如高甘油三酯血症、动脉粥样硬化、糖尿病、过敏和癌症等。